Diligence memo · auto-generated · as of July 2, 2026

Matagorda Lithotripsy LLP

Matagorda Lithotripsy LLP looks under-valued against its niche peers and is at-risk on financing cadence.

WatchOverdue for a raise versus sector cadence — could be a bridge, a down round, or distress. Watch for the next filing.

Businessfiled

Matagorda Lithotripsy LLP operates in Other Health Care, based in TUCSON.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Matagorda Lithotripsy LLP has raised $316K in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).

Largest single filing: $216K on 2013-07-01.

Most recent recorded round closed around 2023-02-28.

Valuation (modeled)modeled

Provath models Matagorda Lithotripsy LLP at approximately $823K (range $63K–$4.2M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Under-valued. Modeled value is 0.32× the median modeled value of Pre-Seed Other Health Care companies in 2022–2024 (288 peers) — value vs value, same stage and era. Issuer reports $0–$1M revenue while modeled below niche peers.

Financing rhythm & timingmixed

Historic cadence: a new round about every 116 months.

Last raise 3.3 yr ago; this sector typically re-raises about every 14 months.

Past due for a raise versus sector cadence — watch for distress or a bridge.

The last round was 2.2× smaller than the prior — a bridge or down round.

Comparablesmixed

Capital scale ranks ahead of 15% of Other Health Care peers (5377 compared).

Modeled value ranks above 5% of those peers.

Closest niche peers: Active Recovery TMS, LLC, Imagen Walled Lake Support Services, LLC, Pinnacle Integrated Medicine, Inc., Choix, Inc., DataBiologics, Inc..

Peoplefiled

3 named people on file across officers, directors and signatories.

Risks & flagsmixed

Overdue for a raise versus sector norm — distress or bridge risk.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.